Description
Key facts
Cell type:HCT116,
Species or organism:Human,
Tissue:Colon,
Form:LiquidSee storage information,
Knockout validation:Sanger Sequencing,Western blot,
Mutation description:Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2,
Disease:Carcinoma
Product details:
We will provide viable cells that proliferate on revival.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our
limited use license
patent pages
Properties and Storage Information:
Gene name-TLE5, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Sanger Sequencing, Western blot, Zygosity-Homozygous, Shipped at conditions-Dry Ice, Appropriate short-term storage conditions--196°C, Appropriate long-term storage conditions--196°C
Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
The Amino-terminal enhancer of split commonly known as AES is a protein with a molecular mass of approximately 22 kDa. It functions as a transcriptional repressor and is involved in controlling gene expression by interacting with DNA. AES is expressed in various tissues including the brain heart and liver indicating its broad role in different biological processes. Its ability to inhibit specific gene expression highlights its involvement in intricate regulatory mechanisms. Researchers also recognize the protein by other names such as enhancer protein and protein enhancer.
Biological function summary
AES interacts with corepressor proteins to form a complex that modulates transcriptional activity. This complex involvement is critical for developmental processes and cell differentiation affecting how cells acquire specialized functions. Through these interactions AES influences the activities of target genes that are essential for organismal development. The presence of AES in significant developmental pathways highlights its regulatory function in cellular mechanisms.
Pathways
AES plays an important role in the Notch signaling and Wnt signaling pathways both integral to cellular differentiation and proliferation. AES specifically interacts with components of these pathways acting to modulate their signaling outcomes. In the Notch signaling pathway AES functions by repressing gene expression therefore maintaining proper cellular balance. Similarly within the Wnt signaling pathway AES interacts with other pathway proteins such as TCF7L2 to adjust gene transcription ensuring normal cellular development and proliferation.
AES has connections to certain types of cancer and neurodevelopmental disorders. Aberrant expression or mutation of AES can lead to disruptions in normal signaling contributing to pathological conditions. In cancer the dysregulation of the Notch signaling pathway where AES plays an important regulatory role is often associated with tumorigenesis. Additionally AES interactions with other proteins like TCF7L2 in Wnt signaling pathways may be implicated in colorectal cancer progression. In neurodevelopmental disorders alterations in the AES function can affect brain development potentially leading to conditions like autism spectrum disorders.
